199 related articles for article (PubMed ID: 20473602)
1. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
[TBL] [Abstract][Full Text] [Related]
2. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
Bradbury AR; Patrick-Miller L; Fetzer D; Egleston B; Cummings SA; Forman A; Bealin L; Peterson C; Corbman M; O'Connell J; Daly MB
Clin Genet; 2011 Feb; 79(2):125-31. PubMed ID: 21039431
[TBL] [Abstract][Full Text] [Related]
3. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jenkins J; Calzone KA; Dimond E; Liewehr DJ; Steinberg SM; Jourkiv O; Klein P; Soballe PW; Prindiville SA; Kirsch IR
Genet Med; 2007 Aug; 9(8):487-95. PubMed ID: 17700386
[TBL] [Abstract][Full Text] [Related]
5. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
[TBL] [Abstract][Full Text] [Related]
6. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
Baumanis L; Evans JP; Callanan N; Susswein LR
J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
[TBL] [Abstract][Full Text] [Related]
8. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
9. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.
Bracke X; Roberts J; McVeigh TP
J Genet Couns; 2021 Apr; 30(2):563-573. PubMed ID: 33131182
[TBL] [Abstract][Full Text] [Related]
11. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
[TBL] [Abstract][Full Text] [Related]
12. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
13. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
Gilmore MJ; Leo MC; Amendola LM; Goddard KAB; Ezzell Hunter J; Joseph G; Kauffman TL; Rolf B; Shuster E; Zepp JM; Wilfond BS; Biesecker BB
Transl Behav Med; 2024 Jun; 14(7):377-385. PubMed ID: 38190737
[TBL] [Abstract][Full Text] [Related]
15. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
16. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
[TBL] [Abstract][Full Text] [Related]
17. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
Padmanabhan H; Hassan NT; Wong SW; Lee YQ; Lim J; Hasan SN; Yip CH; Teo SH; Thong MK; Mohd Taib NA; Yoon SY
PLoS One; 2022; 17(2):e0263675. PubMed ID: 35167615
[TBL] [Abstract][Full Text] [Related]
19. Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.
Takeda M; Ishida T; Ohnuki K; Suzuki A; Sakayori M; Ishioka C; Nomizu T; Noguchi S; Matsubara Y; Ohuchi N
Breast Cancer; 2004; 11(1):30-2. PubMed ID: 14718789
[TBL] [Abstract][Full Text] [Related]
20. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
